超最大强度高强度间歇训练对伴或不伴慢性阻塞性肺疾病者肺外表现的影响与机制(COPD-HIIT):多中心随机对照试验研究方案
COPD-HIIT是一项前瞻性、多中心、随机对照试验,评估12周超最大强度高强度间歇训练(HIIT)对比中等强度持续训练(MICT)对COPD患者(n=92)及匹配健康对照(n=70)肺外表现(认知功能、心肺适能、肌肉功率)的影响,第二阶段纳入常规照护组(n=46)并随访24个月。
要点
- 12周超最大强度HIIT对比MICT,主要结局为认知功能、心肺适能和肌肉功率较基线的变化。
- 第二阶段纳入常规照护组(n=46),评估运动训练与炎症对神经退行性变轨迹的影响,随访24个月。
- 关键次要结局包括运动耐量、MRI脑结构与功能、PET/CT神经炎症、全身炎症和肌肉内适应性。
核心结论
- COPD-HIIT试验将确定超最大强度HIIT对比MICT对COPD患者和健康对照的影响。
- 研究将为一种可能克服COPD患者MICT相关障碍的新型运动模式提供证据。
- 研究还将阐明不同强度运动对减少神经退行性变的影响,目标是改善COPD肺外表现的治疗。
研究设计与样本
- COPD-HIIT为前瞻性、多中心、随机对照试验,采用平行组设计,评估者与数据分析者设盲。
- 第一阶段:12周超最大强度HIIT对比MICT干预,COPD患者n=92,匹配健康对照n=70。
- 参与者每周进行2至3次基于瓦特的功率自行车训练。
- 第二阶段:在COPD患者中确定运动训练和炎症如何影响24个月内神经退行性变的轨迹;除92例进行HIIT或MICT的COPD参与者外,第二阶段纳入常规照护组n=46。
- 试验注册:Clinicaltrials.gov NCT06068322,于2023年9月28日前瞻性注册。
关键数值与推荐
- 两个阶段的主要结局均为认知功能、心肺适能和肌肉功率较基线的变化。
- 关键次要结局包括运动耐量、MRI测量的脑结构和功能、PET/CT测量的神经炎症、全身炎症和肌肉内适应性较基线的变化。
- 将对干预的可行性进行全面评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Beyond being a pulmonary disease, chronic obstructive pulmonary disease (COPD) presents with extrapulmonary manifestations including reduced cognitive, cardiovascular, and muscle function. While exercise training is the cornerstone in the non-pharmacological treatment of COPD, there is a need for new exercise training methods due to suboptimal adaptations when following traditional exercise guidelines, often applying moderate-intensity continuous training (MICT). In people with COPD, short-duration high-intensity interval training (HIIT) holds the potential to induce a more optimal stimulus for training adaptations while circumventing the ventilatory burden often associated with MICT in people with COPD. We aim to determine the effects of supramaximal HIIT and MICT on extrapulmonary manifestations in people with COPD compared to matched healthy controls. METHODS: COPD-HIIT is a prospective, multi-centre, randomized, controlled trial with blinded assessors and data analysts, employing a parallel-group designed trial. In phase 1, we will investigate the effects and mechanisms of a 12-week intervention of supramaximal HIIT compared to MICT in people with COPD (n = 92) and matched healthy controls (n = 70). Participants will perform watt-based cycling two to three times weekly. In phase 2, we will determine how exercise training and inflammation impact the trajectories of neurodegeneration, in people with COPD, over 24 months. In addition to the 92 participants with COPD performing HIIT or MICT, a usual care group (n = 46) is included in phase 2. In both phases, the primary outcomes are a change from baseline in cognitive function, cardiorespiratory fitness, and muscle power. Key secondary outcomes include change from baseline exercise tolerance, brain structure, and function measured by MRI, neuroinflammation measured by PET/CT, systemic inflammation, and intramuscular adaptations. Feasibility of the interventions will be comprehensively investigated. DISCUSSION: The COPD-HIIT trial will determine the effects of supramaximal HIIT compared to MICT in people with COPD and healthy controls. We will provide evidence for a novel exercise modality that might overcome the barriers associated with MICT in people with COPD. We will also shed light on the impact of exercise at different intensities to reduce neurodegeneration. The goal of the COPD-HIIT trial is to improve the treatment of extrapulmonary manifestations of the disease. TRIAL REGISTRATION: Clinicaltrials.gov: NCT06068322. Prospectively registered on 2023-09-28.
引用
- Jakobsson J, Burtin C, Hedlund M, et al. Effects and mechanisms of supramaximal high-intensity interval training on extrapulmonary manifestations in people with and without chronic obstructive pulmonary disease (COPD-HIIT): study protocol for a multi-centre, randomized controlled trial. Trials. 2024. PMID: 39375781. doi:10.1186/s13063-024-08481-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。